Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Paul Bryson
Introduction
Paul Bryson is a notable inventor based in Culver City, California. He has made significant contributions to the field of biomedical engineering, particularly in the development of advanced therapeutic techniques. His work focuses on enhancing the efficacy of cancer treatments through innovative technologies.
Latest Patents
One of Bryson's key inventions is a patent titled "Masking chimeric antigen receptor T cells for tumor-specific activation." This invention is directed to a masked chimeric antigen receptor, which comprises several critical components. These include a masking peptide, one or more antigen-specific targeting domains, an extracellular spacer domain, a transmembrane domain, at least one co-stimulatory domain, and an intracellular signaling domain. The masked chimeric antigen receptors (mCARs) are activated upon cleavage of the masking peptide, providing a targeted approach to tumor treatment. Bryson holds 1 patent for this innovative technology.
Career Highlights
Paul Bryson is affiliated with the University of Southern California, where he continues to advance his research and development efforts. His work has garnered attention for its potential to revolutionize cancer therapies and improve patient outcomes.
Collaborations
Bryson collaborates with Xiaolu Han, a fellow researcher, to further explore the applications of his inventions in clinical settings.
Conclusion
Paul Bryson's contributions to the field of biomedical engineering exemplify the impact of innovative thinking in addressing complex medical challenges. His work on chimeric antigen receptor T cells represents a significant advancement in cancer treatment strategies.